Dynamics of diurnal changes in serum concentration of TNF-α soluble receptors in gastrointestinal cancer patients

Journal of Biological Regulators and Homeostatic Agents

Volumn 14, Issue 3, 2001, Pages 204-208

  Muc Wierzgon M ^a   Baranowski, M M ^a   Madej, K ^a   Wierzgon J ^b   Kokot, T ^a   Brodziak, A ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Advanced neoplasm; Diurnal changes; Soluble receptors; Tumor necrosis factor

Indexed keywords

CYTOKINE; PROTEIN P55; PROTEIN P75; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; AUTOREGULATION; BLOOD LEVEL; CANCER PATIENT; CIRCADIAN RHYTHM; CLINICAL ARTICLE; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DYNAMICS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MEASUREMENT; PANCREAS CANCER; RECEPTOR SOLUBILIZATION; STATISTICAL ANALYSIS; STOMACH CANCER; TIME;

EID: 0035070294     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Aggarwal BB, Natarajan K. Tumor necrosis factor: during the last decade. Eur Cytokine Netw 1996; 7: 93-124.
2. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992; 13: 151-3.
3. Erikstein BK, Smeland EB, Blomhoff HK, et al. Independent regulation of 55-kDa and 75 kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes. Eur J Immunol 1991; 21: 1033-8.
4. Bemelmans MH, Goldman M, Buurmann WA. In vivo T cell activation by auto-DC3-monoclonal antibody induces soluble TNF receptor release in mice. J Immunol 1994; 153: 499-506.
5. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995; 54: 1-8.
6. Aderka D, Engelmann H, Hornik V, Skonick Y, Levo Y, Wallach D. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res 1991; 51: 5602-7.
7. Bemelmans MH, Gouma DJ, Buurman WA. LPS-induced sTNF receptor release in vivo in a murine model. J Immunol 1993; 151: 5554-62.
8. Gatanaga T, Granger GA. Basic and clinical studies of soluble tumor necrosis factor/lymphotoxin receptors. In: Tumor Necrosis Factor: molecular and cellular biology and clinical relevance. Fiers W. and Buurmann WA eds. Basel: Karger,1993; 187-90.
9. Warzocha K, Salles G, Bienvenu J, Bastion Y. TNF ligand-receptor system can predict treatment outcome in lymphoma patients. J Clin Oncol 1997; 15: 499-508.
10. Neylor MS,Stamp GW, Foulkes WD, Eccles D. Balkwill . FR. Tumor necrosis factor and its receptors in disease progression. J Clin Invest 1993; 91: 2194-206.
11. Muc-Wierzgoń M, Madej K, Baranowski MM. Fluctuation of endogenous TNF alpha concentration in plasma in advanced cancer patients. J Biol Regul and Homeost Agents 1996; 10: 25-6.
12. Muc-Wierzgoń M, Madej K, Baranowski MM, Wierzgoń J. Circadian rhythmometry of serum endogenous tumor necrosis factor-alpha in patients with colorectal cancer metastases. Eur Cytokine Netw 1998; 9: 193-6.
13. Touitou Y, Haus E. Biologic rhythms in clinical and laboratory medicine. Berlin, Heidelberg, New York: Springer Verlag, 1994; 687.
14. Burger SA, Grosen EA, Ioli GR, et al. Host-tumor interactions in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro. Gynecol Oncol 1994; 55: 291-303.
15. Fernandez-Botran R. Soluble cytokine receptors: their role in immunoregulation. EASEB J 1994; 5: 2567-74.
16. Liebmann P, Reibnegger G, Lehofer M, Moser M, Prstner P, Schauenstein K. Circadian rhythm of the soluble p-75 TNF-receptor in humans: a possible explanation for the circadian kinetics of TNFα effects. Neuroimmunomodulation 1998; 5; 29.
17. Aderka D, Sorkin P, Abu-Abid S, Lev D, Selton A. Shedding kinetics of soluble TNF receptors after systemic TNF leaking during isolated limb perfusion. J Clin Invest 1998; 10: 650-9.
18. Cope AP, Aderka D, Wallach D, Kahan M, Chu NR, Feldmann M. Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF. Immunology 1995; 84: 21-30.
19. Leenwemberg JFM, Jeunhomme TMA, Buurmann WA. Slow release of soluble TNF receptors by monocytes in vitro. J Immunol 1995; 152: 4036-43.
20. Neuner P, Pourmojib M, Klosner G, Trautinger F, Knobler R. Increased release of the tumour necrosis factor receptor p75 by immortalized human keratinocytes results from an activated shedding mechanism and is not related to augmented steady-state levels of p 75 mRNA. Arch Dermatol Res 1996; 288: 691-6.
21. Langkopf F, Atzpodien J. Soluble tumor necrosis factor receptors as prognostic factors in cancer patients. Lancet 1994; 344: 57-8.